{"id":"NCT00144170","sponsor":"Boehringer Ingelheim","briefTitle":"Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)","officialTitle":"Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) Versus Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients (RESIST 2: Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients With Tipranavir)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-02","primaryCompletion":"2008-10","completion":null,"firstPosted":"2005-09-05","resultsPosted":"2009-12-23","lastUpdate":"2014-07-02"},"enrollment":882,"design":{"allocation":null,"model":"PARALLEL","masking":null,"primaryPurpose":"TREATMENT"},"conditions":["HIV Infections"],"interventions":[{"type":"DRUG","name":"Tipranavir (with low dose ritonavir)","otherNames":[]},{"type":"DRUG","name":"Comparator protease inhibitor(CPI)/low dose ritonavir(r)","otherNames":[]}],"arms":[{"label":"Tipranavir(TPV)/low dose ritonavir(r)","type":"OTHER"},{"label":"Comparator protease inhibitor(CPI)/low dose ritonavir(r)","type":"OTHER"}],"summary":"The objective of this study is to demonstrate the safety and efficacy of tipranavir/ritonavir versus an active control arm in highly treatment experienced Human immunodeficiency virus-1 infected patients. Patients must have a viral load \\> =1000 cells/mL, and genotype indicating at least one resistance conferring protease inhibitor-mutation as determined from a predefined panel of mutations. Any CD4+ count is acceptable.","primaryOutcome":{"measure":"Treatment Response at Week 48","timeFrame":"after 48 weeks of treatment","effectByArm":[{"arm":"Tipranavir(TPV)/Low Dose Ritonavir(r)","deltaMin":34.5,"sd":null},{"arm":"Comparator Protease Inhibitor(CPI)/Low Dose Ritonavir(r)","deltaMin":15,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":174,"countries":["Argentina","Austria","Belgium","Brazil","Denmark","France","Germany","Greece","Ireland","Italy","Mexico","Netherlands","Portugal","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["20003457","16890833"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":123,"n":438},"commonTop":["Diarrhoea","Nausea","Nasopharyngitis","Headache","Pyrexia"]}}